Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

A correlation between cytotoxicity and reductase-mediated metabolism in cell lines treated with doxorubicin and daunorubicin.

Bains OS, Szeitz A, Lubieniecka JM, Cragg GE, Grigliatti TA, Riggs KW, Reid RE.

J Pharmacol Exp Ther. 2013 Nov;347(2):375-87. doi: 10.1124/jpet.113.206805. Epub 2013 Aug 30.

PMID:
23995598
2.

Validation of a sequential extraction and liquid chromatography-tandem mass spectrometric method for determination of dihydrotestosterone, androstanediol and androstanediol-glucuronide in prostate tissues.

Adomat HH, Bains OS, Lubieniecka JM, Gleave ME, Guns ES, Grigliatti TA, Reid RE, Riggs KW.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Aug 1;902:84-95. doi: 10.1016/j.jchromb.2012.06.031. Epub 2012 Jul 1.

PMID:
22818945
3.

Naturally occurring variants of human aldo-keto reductases with reduced in vitro metabolism of daunorubicin and doxorubicin.

Bains OS, Grigliatti TA, Reid RE, Riggs KW.

J Pharmacol Exp Ther. 2010 Dec;335(3):533-45. doi: 10.1124/jpet.110.173179. Epub 2010 Sep 13.

PMID:
20837989
4.

Naturally occurring variants of human CBR3 alter anthracycline in vitro metabolism.

Bains OS, Karkling MJ, Lubieniecka JM, Grigliatti TA, Reid RE, Riggs KW.

J Pharmacol Exp Ther. 2010 Mar;332(3):755-63. doi: 10.1124/jpet.109.160614. Epub 2009 Dec 9.

PMID:
20007405
5.

Two nonsynonymous single nucleotide polymorphisms of human carbonyl reductase 1 demonstrate reduced in vitro metabolism of daunorubicin and doxorubicin.

Bains OS, Karkling MJ, Grigliatti TA, Reid RE, Riggs KW.

Drug Metab Dispos. 2009 May;37(5):1107-14. doi: 10.1124/dmd.108.024711. Epub 2009 Feb 9.

PMID:
19204081
6.

Respiratory and sleep effects of remifentanil in volunteers with moderate obstructive sleep apnea.

Bernards CM, Knowlton SL, Schmidt DF, DePaso WJ, Lee MK, McDonald SB, Bains OS.

Anesthesiology. 2009 Jan;110(1):41-9. doi: 10.1097/ALN.0b013e318190b501.

PMID:
19104169
7.

Functional and energetic characterization of P-gp-mediated doxorubicin transport in rainbow trout (Oncorhynchus mykiss) hepatocytes.

Hildebrand JL, Bains OS, Lee DS, Kennedy CJ.

Comp Biochem Physiol C Toxicol Pharmacol. 2009 Jan;149(1):65-72. doi: 10.1016/j.cbpc.2008.07.003. Epub 2008 Jul 10.

PMID:
18664392
8.

Aldo-keto reductase 1C2 fails to metabolize doxorubicin and daunorubicin in vitro.

Takahashi RH, Bains OS, Pfeifer TA, Grigliatti TA, Reid RE, Riggs KW.

Drug Metab Dispos. 2008 Jun;36(6):991-4. doi: 10.1124/dmd.108.020388. Epub 2008 Mar 5.

PMID:
18322072
9.

Two allelic variants of aldo-keto reductase 1A1 exhibit reduced in vitro metabolism of daunorubicin.

Bains OS, Takahashi RH, Pfeifer TA, Grigliatti TA, Reid RE, Riggs KW.

Drug Metab Dispos. 2008 May;36(5):904-10. doi: 10.1124/dmd.107.018895. Epub 2008 Feb 14.

PMID:
18276838
10.

Cadmium chloride-induced disruption of testicular steroidogenesis in rainbow trout, Oncorhynchus mykiss.

Lizardo-Daudt HM, Bains OS, Singh CR, Kennedy CJ.

Arch Environ Contam Toxicol. 2008 Jul;55(1):103-10.

PMID:
18040592
11.

Biosynthetic capacity of rainbow trout (Oncorhynchus mykiss) interrenal tissue after cadmium exposure.

Lizardo-Daudt HM, Bains OS, Singh CR, Kennedy CJ.

Arch Environ Contam Toxicol. 2007 Jan;52(1):90-6. Epub 2006 Oct 9.

PMID:
17031756
12.
13.

Energetic costs of pyrene metabolism in isolated hepatocytes of rainbow trout, Oncorhynchus mykiss.

Bains OS, Kennedy CJ.

Aquat Toxicol. 2004 Apr 28;67(3):217-26.

PMID:
15063072

Supplemental Content

Loading ...
Support Center